Immune response to sublingual immunotherapy in children allergic to mites

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 4, 2011, Pages 627-634

  Barberi, S ^a   Villa, M P ^a   Pajno, G B ^b   Penna, F L A ^a   Barreto, M ^a   Cardelli, P ^c   Amodeo, R ^c   Tabacco, F ^c   Caminiti, L ^b   Ciprandi, Giorgio ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Children; Cytokine production; House dust mites; Sublingual immunotherapy; T cell subsets

Indexed keywords

ANTIALLERGIC AGENT; CYTOKINE; STALORAL; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MITE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SUBLINGUAL IMMUNOTHERAPY; TH2 CELL; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANIMALS; CHILD; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MITES;

ACARI; PYROGLYPHIDAE;

EID: 84855996065     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Finkelman FD, Vercelli D. Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 2007; 120:544-50. (Pubitemid 47320758)
2. Bousquet J, Lockey RF, Mailing HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy 1998; 53(S):1-42.
3. Mailing HJ, Abreo-Nogueira J, Alvarez-Cuesta E, et al. Local immunotherapy (position paper). Allergy 1998; 53:933-48.
4. Bousquet J, Van Cauwenberg P. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S1-315.
5. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
6. Calamita Z, Saconato H, Bronhara Pelà A, Nagib Atallah A. Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 2006; 61:1162-72. (Pubitemid 44326350)
7. Wilson DR, Nouri-Aria KT, Walker SM, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reduction in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001; 107:971-76. (Pubitemid 32523335)
8. Arikan C, Bahceciler NN, Deniz G, et al. Bacillus Calmette-guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004; 34:398-405. (Pubitemid 38373002)
9. Cosmi L, Santarlasci V, Angeli R, et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10- production. Clin Exp Allergy 2006; 36:261-72. (Pubitemid 43344707)
10. Rolinck-Weminghaus C, Kopp M, Liebke C, Lange J, Wahn U, Niggemann B. Lack of detectable alterations in immune response during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen. Int Arch Allergy Immunol 2005; 136:134-41. (Pubitemid 40463237)
11. Dehlink E, Eiwegger T, Gerstmayr M, et al. Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children. ClinExp Allergy 2006; 36:32-9.
12. Jutel M, Akdis CA. Immunologicalmechanisms of allergen-specific immunotherapy. Allergy 2011; 66:725-32.
13. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363:608-15. (Pubitemid 38264178)
14. Ciprandi G, Fenoglio D, Cirillo I, et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005; 95:38-44. (Pubitemid 41022771)
15. Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, Bousquet J. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62:367-72. (Pubitemid 46398791)
16. Bachert C, Van kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118:375-79. (Pubitemid 29195578)
17. Tang C, Inman MD, van Rooijen N, et al. Th type-1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001; 166:1471-81. (Pubitemid 32114625)
18. Jutel M, Akdis M, Blaser K, Akdis CA. Mechanism of allergen specific immunotherapy-T cell tolerance and more. Allergy 2006; 61:796-807. (Pubitemid 43893981)
19. Lima MT, Wilson D, Pitkin L, et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis : a randomized controlled trial. Clin Exp Allergy 2002; 32:507-14. (Pubitemid 34429567)
20. Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004; 509:498-504. (Pubitemid 38580769)
21. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomised double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116:1073-79. (Pubitemid 41571791)
22. Bahceciler NN, Ariken C, Taylor A, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int Arch Allergy Immunol 2005; 136:287-94. (Pubitemid 40529201)
23. Marcucci F, Sensi L, Di Cara G, et al. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Pediatr Allergy Immunol 2005; 16:519-26. (Pubitemid 41414995)
24. Ippoliti F, De Santis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003; 14:216-21. (Pubitemid 36713381)
25. Fanta C, Bohle B, Hirt W, et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999; 120:218-24.
26. Savolainen J, Nieminem K, Laaksonen K, et al. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy. Allergy 2007; 62:949-53. (Pubitemid 47037859)
27. Mowart AM. The regulation of immune response to dietary proteins. Immunol Today 1987; 8:93-96.
28. Holt PG, Vines J, Britten D. Sublingual allergen administration. I. Selective suppression of IgE production in rats with high allergen doses. Clin Allergy 1988; 18:229-34.
29. Chen Y, Kuchroo VK, Inobe J, et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265:1237-40. (Pubitemid 24291983)
30. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 6552:88-91.
31. Cocks BG, Chang C-Cj, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995; 376:260-63.
32. Asemissen AM, Nagorsen D, Keilholz U, et al. Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. J Immunol Methods 2001; 251:101-8. (Pubitemid 32261061)
33. Schmittel A, Keilholz U, Scheibenbogen C. Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J Immunol Methods 1997; 210:167-74. (Pubitemid 28266560)